rTMS Treatment of Primary Progressive Aphasia

Status Completed

Clinical Trial Summary

Primary Progressive Aphasia (PPA) is a neurodegenerative disease in which language function is gradually and progressively impaired. Patients will eventually be disabled in communication and have cognition deficits, which put a heavy burden not only on their families but also on the whole society. However, no effective treatment for PPA has been explored so far. The current clinical randomized trial is to study the safety and efficacy of repetitive Transcranial Magnetic Stimulation (rTMS) for the treatment of PPA. Also, multi-modality of neuroimaging techniques, such as functional MRI and PET will be used to investigate brain network changing in this procedure.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Aphasia
Aphasia, Primary Progressive
Frontotemporal Dementia
Pick Disease of the Brain
Primary Progressive Aphasia
Repetitive Transcranical Magnetic Stimulation

Clinical Trial Details

NCT number	NCT04431401
Study type	Interventional
Source	Peking Union Medical College Hospital
Contact
Status	Completed
Phase	N/A
Start date	July 1, 2020
Completion date	August 31, 2022

View Details

See also
Status	Clinical Trial	Phase
Suspended	`NCT04290988` - Circuitry Assessment and Reinforcement Training Effects on Recovery	N/A
Recruiting	`NCT04957537` - Semantic Rehabilitation for Patients With Primary Progressive Semantic Aphasia	N/A
Completed	`NCT04045990` - Network Modulation in Alzheimer's Disease	N/A
Recruiting	`NCT05443633` - Enhancing Language Function in Aphasia	N/A
Completed	`NCT05860647` - Transmagnetic Stimulation Pilot in Primary Progressive Aphasia	N/A
Recruiting	`NCT03887481` - Targeting Language-specific and Executive-control Networks With Transcranial Direct Current Stimulation in Logopenic Variant PPA	N/A
Completed	`NCT03728582` - Rehabilitating and Decelerating Language Loss in Primary Progressive Aphasia With tDCS Plus Language Therapy	N/A
Completed	`NCT01465360` - Performance of AclarusDx™, a Blood-Based Transcriptomic Test for AD, in US Patients Newly Referred to a Memory Center	N/A
Completed	`NCT02541097` - Preventing Language Decline in Dementia	N/A
Recruiting	`NCT00537004` - Language in Primary Progressive Aphasia
Recruiting	`NCT05741853` - Cognitive Reserve and Response to Speech-Language Intervention in Bilingual Speakers With Primary Progressive Aphasia	N/A
Active, not recruiting	`NCT05742698` - Nabilone for Agitation in Frontotemporal Dementia	Phase 2
Completed	`NCT02439853` - Communication Bridge Speech Therapy Research Study	N/A
Completed	`NCT01623284` - PiB PET Scanning in Speech and Language Based Dementias	Phase 1
Completed	`NCT04726527` - Clinical Evaluation of Florbetapir in Primary Progressive Aphasia
Completed	`NCT03076671` - More Than a Movement Disorder: Applying Palliative Care to Parkinson's Disease	N/A
Completed	`NCT05537688` - Identification of Graphic Markers of Neurocognitive Disorders (MG)
Completed	`NCT05525377` - Better Living With Non-memory-led Dementia	N/A
Completed	`NCT02928848` - Transcranial Direct Current Stimulation for Primary Progressive Aphasia	N/A
Completed	`NCT04939818` - Clinical Feasibility of Speech Phenotyping for Remote Assessment of Neurodegenerative and Psychiatric Disorders